LGR5 as a Therapeutic Target of Antibody-Functionalized Biomimetic Magnetoliposomes for Colon Cancer Therapy.
Ana CeperoMónica Jiménez-CarreteroYlenia JabaleraLidia GagoCristina LuqueLaura CabezaConsolación MelguizoConcepcion Jimenez-LopezJose Carlos PradosPublished in: International journal of nanomedicine (2024)
Drug-loaded magnetoliposomes functionalized with anti-LGR5 antibodies could be a promising CRC treatment strategy for LGR5+ targeted chemotherapy, magnetic hyperthermia, and both in combination.